Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$369.02 USD

369.02
1,366,185

-0.84 (-0.23%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $369.15 +0.13 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Products

Zacks News

Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.

    McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

    McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

      IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?

      IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.

        What's in Store for Express Scripts (ESRX) in Q2 Earnings?

        Despite an upbeat guidance, cutthroat competition in the niche space is likely to mar Express Scripts' (ESRX) growth in the second quarter.

          Baxter International (BAX) Q2 Earnings: What's in Store?

          Despite an upbeat guidance, lower cyclophosphamide sales are likely to mar Baxter International (BAX) performance in the second quarter 2017.

            Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store?

            Varian Medical Systems' (VAR) oncology business strength might drive its performance in Q3.

              Align Technology (ALGN) Q2 Earnings: A Beat in the Cards?

              Align Technology (ALGN) might ride high in Q2 banking on growth in the Invisalign space.

                Is a Surprise in Store for CR Bard (BCR) in Q2 Earnings?

                Growing adoption of the company's flagship Lutonix drug coated-balloon is expected to benefit C.R. Bard's (BCR) performance in the second quarter.

                  GNC Holdings (GNC) Q2 Earnings: Disappointment in the Cards?

                  We do not expect GNC Holdings (GNC) to beat estimates in Q2 earnings on account of a tough competitive landscape and currency headwinds.

                    Edwards Lifesciences (EW) Q2 Earnings: A Surprise in Store?

                    Edwards Lifesciences (EW) will likely ride high in Q2 earnings banking on continued growth in its highly advanced Transcatheter Heart Valve space.

                      Can Quest Diagnostics (DGX) Pull a Surprise in Q2 Earnings?

                      Weak revenue per requisition performance and reimbursement pressure might dampen Quest Diagnostics' (DGX) benefits from esoteric testing business, infectious disease testing and prescription drug monitoring business growth.

                        Align Technology Hits a 52-Week High on Solid Prospects

                        Share price of San Jose, CA-based Align Technology, Inc. (ALGN) reached a new 52-week high of $157.86 on Jul 17, eventually closing a bit lower at $156.21.

                          Stryker Poised on Solid Product Portfolio and Acquisitions

                          On Jul 17, we issued an updated research report on Kalamazoo, MI-based Stryker Corporation (SYK), one of the largest medical device companies in the global orthopedic market.

                            5 Stocks with Impressive Sales Growth Worth Investing In

                            Sales are often more closely monitored than earnings when assessing the growth of a business.

                              Company News for June 20, 2017

                              Companies in the News are: RICE,EQT,RIGL,NVDQ,SYK,VRX

                                Megan Sanks headshot

                                Novadaq Technologies (NVDQ) Stock Soars 95% on Stryker Acquisition Deal

                                On Monday, NOVADAQ Technologies Inc. (NVDQ) announced that Stryker Corporation (SYK) has agreed to acquire the company for $11.75 per share in cash, putting NOVADAQ's total worth at $701 million.

                                  Stryker (SYK) at 52-Week High: What's Driving the Stock?

                                  Share price of Stryker Corporation (SYK), headquartered in Kalamazoo, MI, scaled a new 52-week high of $141.21 on May 25, eventually closing a little lower at $140.85.

                                    The Zacks Analyst Blog Highlights: Kraft Heinz, Nike, Stryker, DISH Network, TD Ameritrade and Freeport-McMoRan

                                    The Zacks Analyst Blog Highlights: Kraft Heinz, Nike, Stryker, DISH Network, TD Ameritrade and Freeport-McMoRan

                                      Mark Vickery headshot

                                      Top Research Reports for Today: KHC, NKE, SYK & More

                                      Today's Research Daily features new research reports on 16 major stocks, including Kraft Heinz (KHC), Nike (NKE) and Stryker (SYK).

                                        Should You Sell Stryker (SYK) Stock Before Earnings?

                                        Stryker (SYK) might report a beat in the to be reported quarter on the back of its favorable Zacks Rank and positive Earnings ESP.

                                          Medical Product Stocks Earnings on Apr 25: SYK, EW, LH

                                          Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.

                                            Will Stryker (SYK) Deliver a Beat this Earnings Season?

                                            Stryker Corporation (SYK), a leading player in the medical technology space, is set to report first-quarter 2017 results on Apr 25 after the bell.

                                              Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty

                                              Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.

                                                Why Is Stryker Corp (SYK) Up 5% Since the Last Earnings Report?

                                                Stryker Corp (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                                  Stryker (SYK) Beats Q4 Earnings, Provides FY17 Guidance

                                                  Maintaining its streak of positive earnings surprises, Stryker Corp (SYK) reported adjusted earnings of $1.78 per share in the fourth quarter of 2016, which comfortably beat the Zacks Consensus Estimate by 2 cents.